SG152285A1 - Solid pharmaceutical formulation - Google Patents
Solid pharmaceutical formulationInfo
- Publication number
- SG152285A1 SG152285A1 SG200902964-6A SG2009029646A SG152285A1 SG 152285 A1 SG152285 A1 SG 152285A1 SG 2009029646 A SG2009029646 A SG 2009029646A SG 152285 A1 SG152285 A1 SG 152285A1
- Authority
- SG
- Singapore
- Prior art keywords
- pharmaceutical formulation
- solid pharmaceutical
- provides
- formulation
- gelatinized starch
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2004150557 | 2004-05-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
SG152285A1 true SG152285A1 (en) | 2009-05-29 |
Family
ID=35428258
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG200902964-6A SG152285A1 (en) | 2004-05-20 | 2005-05-19 | Solid pharmaceutical formulation |
Country Status (15)
Country | Link |
---|---|
US (1) | US8821936B2 (ru) |
EP (1) | EP1755682A4 (ru) |
KR (2) | KR101302810B1 (ru) |
CN (1) | CN1984682B (ru) |
AR (1) | AR048970A1 (ru) |
AU (1) | AU2005244707B2 (ru) |
BR (1) | BRPI0511298A (ru) |
CA (1) | CA2567400C (ru) |
HK (1) | HK1105358A1 (ru) |
MX (1) | MXPA06013407A (ru) |
MY (1) | MY153696A (ru) |
RU (1) | RU2390332C2 (ru) |
SG (1) | SG152285A1 (ru) |
TW (1) | TWI338583B (ru) |
WO (1) | WO2005113009A1 (ru) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008032767A1 (fr) * | 2006-09-14 | 2008-03-20 | Astellas Pharma Inc. | Comprimé se désintegrant oralement et procédé de fabrication de celui-ci |
GB0618879D0 (en) | 2006-09-26 | 2006-11-01 | Zysis Ltd | Pharmaceutical compositions |
AR071706A1 (es) * | 2008-05-15 | 2010-07-07 | Otsuka Pharma Co Ltd | Una formulacion farmaceutica de cilostazol solida de liberacion sostenida y metodo de preparacion. |
EP3409294A1 (en) | 2017-06-01 | 2018-12-05 | Przedsiebiorstwo Farmaceutyczne Lek-Am Sp Z O. O. | Tablets containing cilostazol of specific particle size distribution |
RU2686066C1 (ru) * | 2018-05-11 | 2019-04-24 | Общество С Ограниченной Ответственностью "Валента-Интеллект" | Лекарственная форма цилостазола замедленного высвобождения |
Family Cites Families (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB825892A (en) * | 1957-05-24 | 1959-12-23 | Ici Ltd | Tabletting process |
US4266348A (en) * | 1978-12-15 | 1981-05-12 | Cpc International Inc. | Fluidized bed process |
GB8624213D0 (en) | 1986-10-09 | 1986-11-12 | Sandoz Canada Inc | Sustained release pharmaceutical compositions |
US4755397A (en) * | 1986-12-24 | 1988-07-05 | National Starch And Chemical Corporation | Starch based particulate encapsulation process |
FR2610827B1 (fr) | 1987-02-18 | 1991-09-13 | Pf Medicament | Comprime de dihydroergotamine (d.h.e.) du type a matrice hydrophile et son procede de fabrication |
FR2618073B1 (fr) * | 1987-07-16 | 1990-09-07 | Pf Medicament | Comprimes de type a matrice hydrophile a base de salbutamol et leur procede de preparation |
US5073380A (en) * | 1987-07-27 | 1991-12-17 | Mcneil-Ppc, Inc. | Oral sustained release pharmaceutical formulation and process |
FR2666506A1 (fr) * | 1990-09-07 | 1992-03-13 | Pf Medicament | Comprime a liberation prolongee a base de 5-mononitrate d'isosorbide et son procede de preparation. |
CN1168102A (zh) | 1995-01-10 | 1997-12-17 | 大制药株式会社 | 树脂微粒及含该树脂微粒的药用材料和药剂 |
JP4022269B2 (ja) * | 1995-05-26 | 2007-12-12 | 協和醗酵工業株式会社 | 医薬組成物 |
WO1997004752A1 (en) | 1995-07-26 | 1997-02-13 | Duramed Pharmaceuticals, Inc. | Pharmaceutical compositions of conjugated estrogens and methods for their use |
DK0869772T3 (da) * | 1995-12-27 | 2002-01-21 | Janssen Pharmaceutica Nv | Bioadhæsiv fast doseringsform |
CN1222317C (zh) * | 1996-07-12 | 2005-10-12 | 第一制药株式会社 | 可迅速崩解的压模物质及其生产方法 |
ES2565163T3 (es) | 1996-10-28 | 2016-03-31 | General Mills, Inc. | Imbibición y encapsulación de partículas de liberación controlada y producto encapsulado |
JPH10182701A (ja) * | 1996-12-26 | 1998-07-07 | Sanei Toka Kk | 溶出性向上粉末及びその製造方法 |
US6129932A (en) * | 1997-09-05 | 2000-10-10 | Merck & Co., Inc. | Compositions for inhibiting platelet aggregation |
JPH11286456A (ja) | 1998-03-31 | 1999-10-19 | Lion Corp | 複合粉体組成物及び錠剤 |
AU3780699A (en) | 1998-05-01 | 1999-11-23 | Rt Alamo Ventures, Inc. | The treatment of sexual dysfunction in certain patient groups |
EP1161941A4 (en) | 1999-03-15 | 2002-08-28 | Kaken Pharma Co Ltd | FAST DELITING TABLETS AND MANUFACTURING METHOD |
EG23951A (en) * | 1999-03-25 | 2008-01-29 | Otsuka Pharma Co Ltd | Cilostazol preparation |
JP4748839B2 (ja) | 1999-03-25 | 2011-08-17 | 大塚製薬株式会社 | シロスタゾール製剤 |
EA005291B1 (ru) | 1999-03-31 | 2004-12-30 | Янссен Фармацевтика Н.В. | Применение предварительно желатинированного крахмала в композиции с контролируемым высвобождением |
FR2798289B1 (fr) * | 1999-09-15 | 2004-12-31 | Cll Pharma | Formes galeniques a delitement rapide en bouche et leur procede de preparation |
US7138143B1 (en) * | 1999-09-30 | 2006-11-21 | Otsuka Pharmaceutical Company, Limited | Coated preparation soluble in the lower digestive tract |
IL151838A0 (en) * | 2000-03-20 | 2003-04-10 | Teva Pharma | Processes for preparing 6-hydroxy-3,4-dihydroquinolinone, cilostazol and n- (4-methoxyphenyl)-3-chloropropionamide |
US6515128B2 (en) * | 2000-03-20 | 2003-02-04 | Teva Pharmaceutical Industries Ltd. | Processes for preparing cilostazol |
JP4637338B2 (ja) * | 2000-09-22 | 2011-02-23 | 大塚製薬株式会社 | シロスタゾール有核錠 |
JP2002193792A (ja) * | 2000-12-25 | 2002-07-10 | Lion Corp | フィルムコーティング錠剤及びエロージョン防止組成物 |
JP2003063965A (ja) | 2001-06-13 | 2003-03-05 | Otsuka Pharmaceut Factory Inc | 注射用シロスタゾール水性製剤 |
US6509040B1 (en) * | 2001-06-22 | 2003-01-21 | R.P. Scherer Corporation | Fast dispersing dosage forms essentially free of mammalian gelatin |
US6596871B2 (en) * | 2001-06-29 | 2003-07-22 | Grayson Walker Stowell | Polymorphic forms of 6-[4-(1-cyclohexyl-1h-tetraol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone |
US6388080B1 (en) * | 2001-06-29 | 2002-05-14 | Grayson Walker Stowell | Polymorphic forms of 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone |
US6531603B1 (en) * | 2001-06-29 | 2003-03-11 | Grayson Walker Stowell | Polymorphic forms of 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone |
CN1210026C (zh) * | 2002-10-09 | 2005-07-13 | 重庆太极医药研究院 | 褪黑素双层控释片及制备工艺 |
MXPA05004422A (es) | 2002-10-25 | 2007-11-22 | Collegium Pharmaceutical Inc | Composiciones de milnacipran de liberacion pulsatil. |
US20050255155A1 (en) * | 2004-05-11 | 2005-11-17 | Glenmark Pharmaceuticals Limited | Modified release cilostazol compositions |
-
2005
- 2005-05-04 TW TW094114355A patent/TWI338583B/zh not_active IP Right Cessation
- 2005-05-09 MY MYPI20052068A patent/MY153696A/en unknown
- 2005-05-19 US US11/596,219 patent/US8821936B2/en not_active Expired - Fee Related
- 2005-05-19 MX MXPA06013407A patent/MXPA06013407A/es active IP Right Grant
- 2005-05-19 WO PCT/JP2005/009583 patent/WO2005113009A1/en active Application Filing
- 2005-05-19 BR BRPI0511298-2A patent/BRPI0511298A/pt not_active IP Right Cessation
- 2005-05-19 CA CA2567400A patent/CA2567400C/en not_active Expired - Fee Related
- 2005-05-19 AR ARP050102057A patent/AR048970A1/es unknown
- 2005-05-19 CN CN2005800239543A patent/CN1984682B/zh not_active Expired - Fee Related
- 2005-05-19 KR KR1020067026736A patent/KR101302810B1/ko active IP Right Grant
- 2005-05-19 RU RU2006145311/15A patent/RU2390332C2/ru not_active IP Right Cessation
- 2005-05-19 SG SG200902964-6A patent/SG152285A1/en unknown
- 2005-05-19 AU AU2005244707A patent/AU2005244707B2/en not_active Ceased
- 2005-05-19 EP EP05743223A patent/EP1755682A4/en not_active Withdrawn
- 2005-05-19 KR KR1020127006492A patent/KR20120030606A/ko not_active Application Discontinuation
-
2007
- 2007-10-03 HK HK07110687.0A patent/HK1105358A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
US20080033009A1 (en) | 2008-02-07 |
CA2567400A1 (en) | 2005-12-01 |
TW200538161A (en) | 2005-12-01 |
KR20070034002A (ko) | 2007-03-27 |
MXPA06013407A (es) | 2007-01-23 |
CN1984682B (zh) | 2012-06-06 |
WO2005113009A1 (en) | 2005-12-01 |
EP1755682A4 (en) | 2012-11-07 |
KR101302810B1 (ko) | 2013-09-02 |
RU2006145311A (ru) | 2008-07-10 |
MY153696A (en) | 2015-03-13 |
AR048970A1 (es) | 2006-06-14 |
TWI338583B (en) | 2011-03-11 |
CA2567400C (en) | 2012-09-25 |
US8821936B2 (en) | 2014-09-02 |
AU2005244707B2 (en) | 2011-08-11 |
KR20120030606A (ko) | 2012-03-28 |
RU2390332C2 (ru) | 2010-05-27 |
EP1755682A1 (en) | 2007-02-28 |
AU2005244707A1 (en) | 2005-12-01 |
HK1105358A1 (en) | 2008-02-15 |
CN1984682A (zh) | 2007-06-20 |
BRPI0511298A (pt) | 2007-12-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2007048219A3 (en) | Sustained drug release composition | |
WO2008107149A3 (de) | Darreichungsform mit erschwertem missbrauch | |
WO2004112711A3 (en) | Oral extended-release composition | |
WO2007008752A3 (en) | Sustained release pharmaceutical compositions for highly water soluble drugs | |
WO2004012700A3 (en) | Dosage form comprising high dose high soluble active ingredient as modified release and low dose active ingredient as immediate release | |
WO2002074247A8 (en) | Pharmaceutical formulations for sustained release | |
MX2007000008A (es) | Formas farmaceuticas orales, protegidas frente al abuso, que contienen (1r,2r)-3-(3-dimetilamino-1-etil-2-metil-propil) fenol. | |
WO2002070438A3 (en) | Compositions for delivering bisphosphonates | |
WO2002019969A3 (en) | (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents | |
NZ524138A (en) | Cyanophenoxy carboxylic acid compounds and compositions for delivering active agents | |
DK1256343T3 (da) | Flibanserin til behandlingen af extrapyramidale bevægelseslidelser | |
CO5060477A1 (es) | Forma de dosificacion de nefazodona | |
HRP20050342B1 (hr) | Farmaceutska formulacija olanzapina | |
IL158668A0 (en) | Deuterated 3-piperidinopropiophenone and medicaments containing said compounds | |
WO2006053089A3 (en) | Methods and formulations for making pharmaceutical compositions containing bupropion | |
SG152285A1 (en) | Solid pharmaceutical formulation | |
WO2005065639A3 (en) | Novel pharmaceutical compositions | |
IL179177A (en) | A pharmaceutical product including acyclovir and delivery compound, dosage unit, use of acyclovir in the preparation of the pharmaceutical product, use of the pharmaceutical product in the preparation of a drug and a method for the preparation of the pharmaceutical product | |
WO2011083402A3 (en) | Immediate release compositions of acid labile drugs | |
MY153109A (en) | A solid pharmaceutical formulation | |
WO2008004100A3 (en) | Therapeutic compounds | |
UA89656C2 (ru) | Фармацевтическая композиция, которая диспергируется перорально, и способ ее приготовления | |
WO2007031326A3 (de) | Retardformulierung von 3-(2-dimethylaminomethyl-cyclohexyl)-phenol | |
TNSN06072A1 (en) | Use of oxcarbazepine for the treatment of diabetic neuropathic pain and the improvement of sleep | |
WO2004071398A3 (en) | Pharmaceutical patch |